Taysha Gene Therapies, Inc. TSHA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s total liabilities?
- Taysha Gene Therapies, Inc. (TSHA) reported total liabilities of $88.41M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s total liabilities changed year-over-year?
- Taysha Gene Therapies, Inc.'s total liabilities increased by 6.1% year-over-year, from $83.3M to $88.41M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s total liabilities has grown at a 66.3% compound annual growth rate (CAGR), from $7.58M to $96.38M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.